Shares of Thermo Fisher Scientific TMO rose 2% in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were up 91.50% over the past year to $5.63, which beat the estimate of $4.31.
Revenue of $8,521,000,000 up by 35.86% from the same period last year, which beat the estimate of $7,650,000,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: Oct 21, 2020
Time: 08:30 AM
Technicals
Company's 52-week high was at $473.84
52-week low: $250.21
Price action over last quarter: Up 14.01%
Company Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (22% of sales); specialty diagnostic products (15%); life science solutions (27%); and lab products and services (42%).
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.